miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer-Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer
- PMID: 38139300
- PMCID: PMC10743418
- DOI: 10.3390/ijms242417470
miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer-Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer
Abstract
Endometriosis-associated ovarian cancer (EOC) consisting of endometrioid cancer and clear-cell ovarian cancer could be promoted by many factors. miRNAs, which are small, non-coding molecules of RNA, are among them. The aim of this study was to detect miRNAs connected with the malignant transformation of endometriosis. FFPE (formalin-fixed, paraffin-embedded) samples of 135 patients operated on for endometriosis and different types of ovarian cancer (EOC and HGSOC-high-grade serous ovarian cancer) were studied. Healthy ovarian tissue was used as a control group. From the expression panel of 754 miRNAs, 7 were chosen for further tests according to their ROC (receiver operating characteristic) curves: miR-1-3p, miR-125b-1-3p, miR-31-3p, miR-200b-3p, miR-502-5p, miR-503-5p and miR-548d-5p. Furthermore, other potentially important clinical data were analysed, which included age, BMI, Ca-125 concentration, miscarriages and deliveries and concomitant diseases such as hypertension, type 2 diabetes and smoking. Among the miRNAs, miR200b-3p had the lowest expression in neoplastic tissues. miR31-3p had the highest expression in women without any lesions in the ovaries. miR-502-5p and miR-548-5p did not differ between the studied groups. The examined miRNA panel generally distinguished significantly normal ovarian tissue and endometriosis, normal ovarian tissue and cancer, and endometriosis and cancer. The malignant transformation of endometriosis is dependent on different factors. miRNA changes are among them. The studied miRNA panel described well the differences between endometriosis and EOC but had no potential to differentiate types of ovarian cancer according to their origin. Therefore, examination of a broader miRNA panel is needed and might prove itself advantageous in clinical practice.
Keywords: carcinogenesis; endometrial cyst; endometriosis; miRNA; ovarian cancer.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
Figures
Similar articles
-
miR 31-3p Has the Highest Expression in Cesarean Scar Endometriosis.Int J Mol Sci. 2022 Apr 22;23(9):4660. doi: 10.3390/ijms23094660. Int J Mol Sci. 2022. PMID: 35563053 Free PMC article.
-
Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.Hum Reprod. 2015 Oct;30(10):2292-302. doi: 10.1093/humrep/dev204. Epub 2015 Aug 25. Hum Reprod. 2015. PMID: 26307093
-
miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples.Onco Targets Ther. 2017 Aug 28;10:4225-4238. doi: 10.2147/OTT.S137107. eCollection 2017. Onco Targets Ther. 2017. PMID: 28894379 Free PMC article.
-
miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.Oncotarget. 2016 Dec 6;7(49):81621-81633. doi: 10.18632/oncotarget.13154. Oncotarget. 2016. PMID: 27835595 Free PMC article. Review.
-
Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis.Int J Mol Sci. 2019 Oct 25;20(21):5322. doi: 10.3390/ijms20215322. Int J Mol Sci. 2019. PMID: 31731537 Free PMC article. Review.
Cited by
-
Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance.Int J Mol Sci. 2024 Apr 13;25(8):4306. doi: 10.3390/ijms25084306. Int J Mol Sci. 2024. PMID: 38673891 Free PMC article. Review.
-
Inflammatory index is a promising biomarker for maintenance hemodialysis patients with cardiovascular disease.Eur J Med Res. 2024 Nov 13;29(1):544. doi: 10.1186/s40001-024-02117-7. Eur J Med Res. 2024. PMID: 39533444 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous